|
PF-20602 |
HAVRIX 720 Dosis Pediátrica Suspensión Inyectable |
2028-12-06 |
|
GlaxoSmithkline Biologicals, S.A. |
Bélgica
|
Glaxosmithkline Guatemala |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-26096 |
HAVRIX 1440, 1440 U. Elisa Suspensión inyectable |
2026-03-26 |
|
GlaxoSmithkline Biologicals, S.A. |
Bélgica
|
Vacuna |
Glaxosmithkline Guatemala |
Centro Distribuidor, Sociedad Anónima |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-24528 |
ENGERIX B Junior 10 mcg/0.5 mL Suspensión inyectable |
2027-04-25 |
|
GlaxoSmithkline Biologicals, S.A. |
Bélgica
|
Glaxosmithkline Guatemala |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-24612 |
VARILRIX Polvo y solvente para solución inyectable |
2022-01-29 |
|
GlaxoSmithkline Biologicals, S.A. |
Bélgica
|
Glaxosmithkline Guatemala |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-28860 |
POLIO SABIN, vacuna oral de poliomielitis, suspension oral |
2007-10-02 |
|
GlaxoSmithkline Biologicals, S.A. |
Bélgica
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-28861 |
ENGERIX B 20 mcg/mL suspension inyectable |
2027-07-22 |
|
GlaxoSmithkline Biologicals, S.A. |
Bélgica
|
J.I.Cohen, S.A. |
Vacuna |
Glaxosmithkline Guatemala |
Centro Distribuidor, Sociedad Anónima |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-29693 |
MECEVAX AC Liofilizado y solucion para uso parenteral |
2008-02-10 |
|
GlaxoSmithkline Biologicals, S.A. |
Bélgica
|
Glaxosmithkline Guatemala S.A. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-19366 |
HIBERIX 10 mcg/0.5 mL Polvo liofilizado y solución para uso parenteral |
2018-12-05 |
|
GlaxoSmithkline Biologicals, S.A. |
Bélgica
|
Glaxosmithkline Guatemala |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-39810 |
CUTIVATE 0.05 % Crema tópica |
2026-09-23 |
|
Glaxosmithkline Brasil Ltda. |
Brasil
|
Glaxosmithkline Guatemala |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-39845 |
ZOVIRAX 5% Crema Tópica |
2028-01-06 |
|
Glaxosmithkline Brasil Ltda. |
Brasil
|
J.I.Cohen, S.A. |
Glaxosmithkline Guatemala |
Centro Distribuidor, Sociedad Anónima |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|